[Inflammatory bowel disease and venous thromboembolisms]

Area of Science:

• Gastroenterology
• Hematology
• Internal Medicine

Background:

• Inflammatory Bowel Diseases (IBD) are linked to significant extra-intestinal complications.
• Venous and arterial thromboembolisms are major causes of morbidity and mortality in IBD patients.
• These thrombotic events frequently coincide with IBD flares and are often triggered by acquired factors.

Purpose of the Study:

• To review the epidemiological and etiological characteristics of thromboembolic events in IBD.
• To discuss the prevention and management strategies for these complications.
• To focus specifically on venous thromboembolisms within the context of IBD.

Main Methods:

• Literature review focusing on epidemiological and etiological data.
• Analysis of current prevention and management guidelines for thromboembolism in IBD.
• Synthesis of information regarding the use of heparin for prophylaxis.

Main Results:

• IBD is a significant risk factor for venous thromboembolism.
• Heparin is an effective preventive measure but is underused.
• Recent guidelines support expanded use of heparin, including for outpatients.

Conclusions:

• Thromboembolism is a critical extra-intestinal manifestation of IBD requiring vigilant management.
• Optimizing the use of prophylactic heparin is crucial for reducing morbidity and mortality.
• Further research and adherence to updated guidelines are needed for effective prevention and treatment.